Skip to main content
logo
TRex Bio, Inc. (TRXB)
TRex Bio will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

TRex Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending
TTMDec '25 Dec '24
Net Income
-46.39-34.81-8.89
Depreciation & Amortization
-2-1.550.67
Share-Based Compensation
-0.450.25
Other Operating Activities
2.14-5.46-23.35
Operating Cash Flow
-46.25-41.36-25.58
Operating Cash Flow Growth
---

Investing Activities

Year Ending
TTMDec '25 Dec '24
Capital Expenditures
-0.06-0.07-0.07
Change in Investments
--32.92-17.24
Investing Cash Flow
-28.26-32.99-17.3

Financing Activities

Year Ending
TTMDec '25 Dec '24
Share Issuance / Repurchase
-42.0741.85
Financing Cash Flow
49.642.0741.85

Net Cash Flow

Year Ending
TTMDec '25 Dec '24
Net Cash Flow
-24.91-32.28-1.04

Free Cash Flow

Year Ending
TTMDec '25 Dec '24
Free Cash Flow
-46.31-41.43-25.65
Free Cash Flow Growth
---
Free Cash Flow Margin
---65.59%